Login / Signup

Sponsorship of oncology clinical trials in the United States according to age of eligibility.

Dylan V NeelDavid S ShulmanClement MaFlorence BourgeoisSteven G DuBois
Published in: Cancer medicine (2020)
Interventional oncology trials that include patients < 18 years are less likely to be industry-sponsored compared to oncology trials exclusively in patients ≥ 18 years. Compared to other medical disciplines, a smaller proportion of industry-sponsored oncology trials included patients < 18 years. Trial sponsorship is associated with differential trial characteristics, such as trial duration and number of patients enrolled, regardless of age.
Keyphrases
  • end stage renal disease
  • clinical trial
  • newly diagnosed
  • chronic kidney disease
  • palliative care
  • prognostic factors
  • healthcare
  • study protocol
  • patient reported outcomes
  • phase iii
  • patient reported